Skip to content
Disclosery

Paradigm Biocapital Advisors LP: ACLX position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Paradigm Biocapital Advisors LP on ACLX, newest first. How the timeline and the estimate are built.

Paradigm Biocapital Advisors LP held 0 ACLX shares at 2026-06-30 per its 13F-HR filed 2026-08-14.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 0 shares
    Change vs previous 13F -5,774,016 shares

    13F-HR 0001855655-26-000014 filed by Paradigm Biocapital Advisors LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

    Exited: the 13F for this period no longer lists the position.

  2. period ended2026-03-31
    13F 5,774,016 shares
    Change vs previous 13F +50,000 shares

    13.55% of the 13F portfolio, value $662,972,517.

    13F-HR 0001855655-26-000011 filed by Paradigm Biocapital Advisors LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 5,724,016 shares
    Change vs previous 13F +1,075,000 shares

    9.99% of the 13F portfolio, value $373,205,843.

    13F-HR 0001855655-26-000003 filed by Paradigm Biocapital Advisors LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 4,649,016 shares
    Change vs previous 13F 0 shares

    11.29% of the 13F portfolio, value $381,684,214.

    13F-HR 0001855655-25-000014 filed by Paradigm Biocapital Advisors LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 4,649,016 shares
    Change vs previous 13F +156,984 shares

    13.07% of the 13F portfolio, value $306,137,704.

    13F-HR 0001855655-25-000010 filed by Paradigm Biocapital Advisors LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2025-03-31
    13F 4,492,032 shares
    Change vs previous 13F +120,431 shares

    13.56% of the 13F portfolio, value $294,677,299.

    13F-HR 0001855655-25-000007 filed by Paradigm Biocapital Advisors LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2024-12-31
    13F 4,371,601 shares
    Change vs previous 13F +371,601 shares

    11.66% of the 13F portfolio, value $335,258,081.

    13F-HR 0001855655-25-000004 filed by Paradigm Biocapital Advisors LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2024-09-30
    13F 4,000,000 shares
    Change vs previous 13F not available

    11.69% of the 13F portfolio, value $334,040,000.

    13F-HR 0001855655-24-000014 filed by Paradigm Biocapital Advisors LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).